Professor, Neurology, University of Texas Medical School, Houston
Neurology
Dr. William G. Ondo, MD
|
|
Give Review
William G. Ondo works in the field of Neurology. He researched medicine at Virginia Commonwealth University School of Medicine. He has 1 awards "Super Doctor". William Ondo is a published doctor as well. He has 98 publications published. The latest was: Tardive dyskinesia and pseudo-parkinsonism. In a nursing home patient who itched. William Ondo accepts Medicare payments and is listed with Medicare.gov.
Publications
- Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.
- Role of apomorphine in the treatment of Parkinson's Disease.
- Restless legs Syndrome: pathophysiology and treatment.
- Does Idiopathic Restless Legs Syndrome Delay Onset and Reduce Severity of Parkinson's Disease: A Pilot Study.
- IPX066 , a mixed immediate/sustained-release levodopa preparation for Parkinson's Disease.
- Sleep/wake problems in Parkinson's Disease: pathophysiology and clinicopathologic correlations.
- Restless legs Syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria - history, ration...
- Effects of deep brain stimulation in relatively young-onset Multiple system atrophy Parkinsonism.
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit.
- Orthostatic Tremor: A review of 45 cases.
- Common comorbidities and differential diagnosis of restless legs Syndrome.
- Habituation and Rebound to Thalamic Deep Brain Stimulation in Long-Term Management of Tremor Associated with Demyelinating Neuropathy.
- Paraspinal muscle asymmetry in Parkinson's Disease.
- Exome sequencing in familial corticobasal degeneration.
- Predictors of placebo response in restless legs Syndrome studies.
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's Disease and motor fluctuations: a phase 3 ...
- Movements Mimicking Myoclonus Associated with Spinal Cord Pathology: Is this a "Pure Motor Restless Legs Syndrome".
- Globus pallidus deep brain stimulation for refractory idiopathic restless legs Syndrome.
- Dextromethorphan/Quinidine for Chorea: an open-label assessment.
- Stereotypies as a manifestation of acute hyperglycemia without ketosis.
- Task specific writing Tremor: clinical phenotypes, progression, treatment outcomes, and proposed nomenclature.
- Correction: genome-wide association study identifies novel restless legs Syndrome susceptibility Loci on 2p14 and 16q12.1.
- Genome-wide association study identifies novel restless legs Syndrome susceptibility Loci on 2p14 and 16q12.1.
- Family-based and population-based association studies validate PTPRD as a risk factor for restless legs Syndrome.
- Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, cr...
- Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States.
- Levodopa-induced dyskinesias in spinocerebellar Ataxia type 2.
- Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson Disease.
- Treatment of fragile-X-associated tremor/Ataxia syndrome with deep brain stimulation.
- Sodium oxybate for excessive daytime sleepiness in Parkinson Disease: an open-label polysomnographic study.
- Zonisamide for Essential tremor.
- Withdrawal of visual feedback improves micrographia in Parkinson's Disease.
- Placebo response in Parkinson trials using patient diaries: sites do matter.
- Selegiline orally disintegrating tablets in patients with Parkinson Disease and "wearing off" symptoms.
- Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs Syndrome.
- Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.
- Animal studies in restless legs Syndrome.
- Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's Disease.
- Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation.
- Tetrabenazine for hyperglycemic-induced hemiChorea-hemiballismus.
- Intravenous flumazenil for Parkinson's Disease: a single dose, double blind, placebo controlled, cross-over trial.
- Subthalamic deep brain stimulation in patients with a previous pallidotomy.
- Essential tremor: treatment options.
- Association between restless legs Syndrome and essential tremor.
- Long-term evaluation of deep brain stimulation of the thalamus.
- Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
- A pilot study of botulinum toxin A for headache in cervical Dystonia.
- Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's Disease.
- Olfaction testing in patients with tremor-dominant Parkinson's Disease: is this a distinct condition?
- Methadone for refractory restless legs Syndrome.
- An open-label pilot study of levetiracetam for Essential tremor.
- Genomewide linkage scan identifies a novel susceptibility locus for restless legs Syndrome on chromosome 9p.
- A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's Disease.
- Basal ganglia neuronal discharge in primary and secondary Dystonia.
- Association study of Parkin gene polymorphisms with idiopathic Parkinson Disease.
- Basal ganglia neuronal discharge in primary and secondary Dystonia in patients undergoing pallidotomy.
- Flumazenil, a GABA antagonist, may improve features of Parkinson's Disease.
- Parkin mutations and susceptibility alleles in late-onset Parkinson's Disease.
- Mitochondrial polymorphisms significantly reduce the risk of Parkinson Disease.
- Tetrabenazine treatment for Huntington's Disease-associated chorea.
- Olanzapine treatment for dopaminergic-induced hallucinations.
- Exploring the relationship between Parkinson disease and restless legs Syndrome.
- Physiological assessment of paroxysmal Dystonia secondary to subacute sclerosing panencephalitis.
- Vascular Parkinsonism: clinical correlates predicting motor improvement after lumbar puncture.
- Ambulatory monitoring of freezing of gait in Parkinson''s Disease.
- The metric properties of a novel non-motor symptoms scale for Parkinson's Disease: Results from an international pilot study.
- Predictors of impulsivity and reward seeking behavior with dopamine agonists.
- Locomotor response to levodopa in fluctuating Parkinson''s Disease.
- Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in Essential tremor.
- Predictors of battery life for the Activa Soletra 7426 Neurostimulator.
- Short-term and long-term safety of deep brain stimulation in the treatment of movement Disorders.
- Animal models of restless legs Syndrome.
- G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with Multiple system atrophy.
- Deep brain stimulation: preoperative issues.
- Long-term monitoring of gait in Parkinson''s Disease.
- A pilot study of the clinical efficacy and safety of memantine for Huntington''s Disease.
- Practice Parameter: treatment of Parkinson Disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of t...
- International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's Disease: the NMSQuest study.
- Modafinil for daytime somnolence in Parkinson''s Disease: double blind, placebo controlled parallel trial.
- Topiramate in Essential tremor: a double-blind, placebo-controlled trial.
- VIM deep brain stimulation does not improve pre-existing restless legs Syndrome in patients with essential tremor.
- The North American survey of placement and adjustment strategies for deep brain stimulation.
- Projections of diencephalic dopamine neurons into the spinal cord in mice.
- Practice parameter: therapies for Essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
- Neuropathological examination suggests impaired brain iron acquisition in restless legs Syndrome.
- Evaluating factors that can influence spirography ratings in patients with Essential tremor.
- Long-term treatment of restless legs Syndrome with dopamine agonists.
- Ropinirole is effective in the treatment of restless legs Syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
- Hearing impairment in Essential tremor.
- Epidemiology of restless legs Syndrome.
- Vagus nerve stimulation for Essential tremor: a pilot efficacy and safety trial.
- Botulinum toxin A for chronic daily Headache: a randomized, placebo-controlled, parallel design study.
- Gait and balance disorders.
- Benefits and risks of pharmacological treatments for Essential tremor.
- Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's Disease.
- When to worry about headache. Head pain as a clue to intracranial Disease.
- Tardive dyskinesia and pseudo-Parkinsonism. In a nursing home patient who itched.
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Ataxia
- Brachial Plexus Palsy
- Carpal Tunnel Syndrome
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Sleep Medicine
- Neurology
Accepted Insurances
Awards
- Super Doctor
Education
-
Duke University Hospital -
University of North Carolina Hospitals -
Virginia Commonwealth University School of Medicine
Drug Facts
| NPI NUMBER | 1851471437 | |
| NPPES Provider LastName | ONDO | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 770305301 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 2941.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 45.0 | |
| Percent Opioid Claims | 1.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851471437 |
| Last Name Of The Provider | ONDO |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Navdeep S. Sangha, MD |
|
|
Dr. Lisa A. Miller, MD |
|
|
Dr. Michael V. Abene, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kasey L. Gildersleeve, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana Lebron, MD
This Doctor is OpenDoctor Recommended.
|